Clinical trial
A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In…
NCT00453349 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00453349 |
|---|---|
| Title | A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease |
| Official title | A Prospective, Randomized, Double Dummy, Double Blind, Multi-center Multinational Trial Comparing the Efficacy and Safety of Moxifloxacin 400 mg PO QD 24 Hours for 14 Days to That of Levofloxacin 500 mg PO QD 24 Hours Plus Metronidazole 500 mg BID for 14 Days in Subjects With an Uncomplicated Pelvic… |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pelvic Inflammatory Disease |
| Intervention type | Drug |
| Interventions | Moxifloxacin (Avelox, BAY12-8039), Levofloxacin & Metronidazole |
| Enrollment | 460 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Mar 28, 2007 |
| Last update posted | Sep 8, 2014 |
| Countries | China, Indonesia, Pakistan, Philippines, South Korea, Taiwan, Thailand |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: